Proliferation and Chromosomal Changes Predict Survival in Young Astrocytoma Patients
Author Information
Author(s): Wessels P H, Hopman A H N, Kubat B, Kessels A G H, Hoving E W, Ummelen M I J, Ramaekers F C S, Twijnstra A
Primary Institution: University Hospital Maastricht
Hypothesis
Can proliferation activity and chromosomal aberrations predict survival in young patients with astrocytoma grade II?
Conclusion
The study found that high proliferation activity and chromosomal abnormalities are associated with shorter survival in young patients with astrocytoma grade II.
Supporting Evidence
- Proliferation index >1% was significantly associated with shorter survival.
- Aneusomy was detected in 68% of the tumors studied.
- Patients aged 18–34 with a high proliferation index had a similar prognosis to older patients.
- Median survival for patients with astrocytoma grade II was 90 months.
Takeaway
Doctors can tell how long young patients with a certain brain tumor might live by looking at how fast the tumor cells are growing and if there are any unusual chromosomes.
Methodology
The study analyzed tissue specimens from 47 patients, assessing proliferation index and chromosomal status to evaluate their correlation with survival.
Potential Biases
Potential sampling bias due to exclusion of certain cases suspected to be high-grade astrocytomas.
Limitations
The study's sample size was relatively small, which may limit the generalizability of the findings.
Participant Demographics
Mean age was 38 years, with 22 women (47%) and 25 men (53%).
Statistical Information
P-Value
0.05
Confidence Interval
72–108 months
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website